The Challenges and Potential of Clinical Trials in Dementia Research

Prof. Matthew Kiernan

Chief Executive Officer and Institute Director, Neuroscience Research Australia Scientia Professor of Neuroscience at the University of New South Wales, Sydney, Australia Senior Staff Specialist in Neurology, South Eastern Sydney Local Health District

This video delves into the complexities of clinical trials and treatment for dementia. Professor Dr. Matthew Kiernan discusses the limitations of current trial models, the need for personalized biomarkers, and the challenges of using a one-size-fits-all approach.

Learn more about Alzheimer’s Disease and Dementia here